open access

Vol 72, No 1 (2022)
Guidelines / Expert consensus
Published online: 2022-02-09
Get Citation

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski1, Dominik Dziurda2, Mariusz Bidziński3, Barbara Bobek-Bilewicz4, Marek Dedecjus5, Iwona Hus6, Beata Jagielska7, Jacek Jassem8, Andrzej Kawecki9, Dariusz Kowalski10, Magdalena Krasztel2, Maciej Krzakowski11, Tomasz Kubiatowski12, Piotr Potemski1314, Radosław Mądry15, Piotr Rutkowski16, Anna Rychert2, Janusz Ryś17, Krzysztof Składowski18, Rafał Tarnawski4, Hanna Tchórzewska-Korba19, Andrzej Tysarowski20, Piotr J. Wysocki21, Roman Topór-Mądry2
·
Nowotwory. Journal of Oncology 2022;72(1):44-50.
Affiliations
  1. Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  2. The Agency for Health Technology Assessment and Tariff System (AOTMiT), Warsaw, Poland
  3. Department of Gynecologic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  4. Department of Radiology and Imaging Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland
  5. Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  6. Institute of Hematology and Transfusion Medicine, Warsaw, Poland
  7. Grochowski Hospital, Warsaw, Poland
  8. Department and Clinic of Oncology and Radiotherapy, Medical University, Gdańsk, Poland
  9. Department of Head and Neck Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  10. Department of Oncological Radiotherapy and Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  11. Department of Lung Cancer and Chest Tumors, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  12. Department of Oncology and Immunooncology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland
  13. Chemotherapy Clinic, Oncology Department, Medical University, Lodz, Poland
  14. Nicolaus Copernicus Multidisciplinary Centre of Oncology and Traumatology, Lodz, Poland
  15. Department of Gynecological Oncology, Poznan University of Medical Sciences, Poznan, Poland
  16. Department of Soft Tissue-Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  17. Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland
  18. Department of Radiology and Imaging Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland
  19. Department of Rehabilitation, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  20. Independent Laboratory of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
  21. Department and Clinic of Oncology, Jagiellonian University Medical College, Krakow, Poland

open access

Vol 72, No 1 (2022)
Guidelines and recommendations
Published online: 2022-02-09

Abstract

Introduction.As the changes leading to improvement of cancer care in Poland have shown the need to introduce clinical practice guidelines into the health care system, it has become clear that no methodological standard of the process for guidelines preparation has been established so far. The following process aims to present a unified and comprehensive clinical practice guidelines (CPGs) development methodology.

Materials and methods.A review of globally recognised methods used by guideline development groups was prepared, informing the discussion during three plenary meetings and extensive consultations in writing. The resulting document was unanimously approved by a group of 24 methodologists and clinical experts, and has been formally recognized as a standard for CPGs development by the management of the National Institute of Oncology and the Agency for Health Technology Assessment and Tariff System.

Results.Within the process, 43 recommendations were formulated to create unified and comprehensive rules for guideline development within the Polish healthcare system.

Conclusions.The presented methods are consistent with the globally recognized tools and methods of guideline development, such as GRADE and ADAPTE, and follow quality criteria described by AGREE II. The process supports the development of high-quality guidelines within a resource-constrained setting by allowing to choose between adoption, adaptation, or de novo development of either the whole document of guidelines or particular recommendations.

Abstract

Introduction.As the changes leading to improvement of cancer care in Poland have shown the need to introduce clinical practice guidelines into the health care system, it has become clear that no methodological standard of the process for guidelines preparation has been established so far. The following process aims to present a unified and comprehensive clinical practice guidelines (CPGs) development methodology.

Materials and methods.A review of globally recognised methods used by guideline development groups was prepared, informing the discussion during three plenary meetings and extensive consultations in writing. The resulting document was unanimously approved by a group of 24 methodologists and clinical experts, and has been formally recognized as a standard for CPGs development by the management of the National Institute of Oncology and the Agency for Health Technology Assessment and Tariff System.

Results.Within the process, 43 recommendations were formulated to create unified and comprehensive rules for guideline development within the Polish healthcare system.

Conclusions.The presented methods are consistent with the globally recognized tools and methods of guideline development, such as GRADE and ADAPTE, and follow quality criteria described by AGREE II. The process supports the development of high-quality guidelines within a resource-constrained setting by allowing to choose between adoption, adaptation, or de novo development of either the whole document of guidelines or particular recommendations.

Get Citation

Keywords

practice guidelines; oncology; guidelines development; consensus

About this article
Title

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Journal

Nowotwory. Journal of Oncology

Issue

Vol 72, No 1 (2022)

Article type

Guidelines / Expert consensus

Pages

44-50

Published online

2022-02-09

Page views

5392

Article views/downloads

437

DOI

10.5603/NJO.2022.0005

Bibliographic record

Nowotwory. Journal of Oncology 2022;72(1):44-50.

Keywords

practice guidelines
oncology
guidelines development
consensus

Authors

Jan Walewski
Dominik Dziurda
Mariusz Bidziński
Barbara Bobek-Bilewicz
Marek Dedecjus
Iwona Hus
Beata Jagielska
Jacek Jassem
Andrzej Kawecki
Dariusz Kowalski
Magdalena Krasztel
Maciej Krzakowski
Tomasz Kubiatowski
Piotr Potemski
Radosław Mądry
Piotr Rutkowski
Anna Rychert
Janusz Ryś
Krzysztof Składowski
Rafał Tarnawski
Hanna Tchórzewska-Korba
Andrzej Tysarowski
Piotr J. Wysocki
Roman Topór-Mądry

References (14)
  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209–249.
  2. Hofmarcher T, Lindgren P, Wilking N, et al. The cost of cancer in Europe 2018. Eur J Cancer. 2020; 129: 41–49.
  3. Graham R. Institute of Medicine (U.S.), Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust. National Academies Press, Washington 2011: xxxiv, 266.
  4. Brouwers MC, Kho ME, Browman GP, et al. AGREE Next Steps Consortium. The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. J Clin Epidemiol. 2012; 65(5): 526–534.
  5. Leśniak W, Bała M, Jaeschke R, et al. Od danych naukowych do praktycznych zaleceń – tworzenie wytycznych według metodologii GRADE. Polish Archives of Internal Medicine. 2015; 125(Special Issue): 26–41.
  6. Agencja Oceny Technologii Medycznych i Taryfikacji. Metodyka opracowywania wytycznych praktyki klinicznej w onkologii. Opracowanie przygotowane w ramach projektu „Wsparcie procesu poprawy jakości w leczeniu onkologicznym oraz zmiana organizacji systemu opieki zdrowotnej w zakresie onkologii. Material not published 2020.
  7. The ADAPTE Collaboration. The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2.02009.
  8. Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol. 2017; 81: 101–110.
  9. European Society for Medical Oncology. Standard Operating Procedures (SOPs) for Authors and templates for ESMO Clinical Practice Guidelines (CPGs) and ESMO-MCBS Scores 2021. https://www.esmo.org/content/download/77789/1426712/file/ESMO-Clinical-Practice-Guidelines-Standard-Operating-Procedures.pdf.
  10. The National Comprehensive Cancer Network. About the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) 2020. https://www.nccn.org/professionals/default.aspx.
  11. Rychert A, Dziurda D, Koperny M, et al. Systems for grading the strength of recommendations in clinical practice guidelines in oncology. Material not published .
  12. Yao X, Ma J, Wang Qi, et al. A Comparison of AGREE and RIGHT: which Clinical Practice Guideline Reporting Checklist Should Be Followed by Guideline Developers? J Gen Intern Med. 2020; 35(3): 894–898.
  13. Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650): 924–926.
  14. Schünemann HJ, Wiercioch W, Etxeandia I, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014; 186(3): E123–E142.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl